GE Healthcare Technologies Inc (GEHC) Stock AnalysisGEHCGE Healthcare Technologies Inc

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).

GE Healthcare Technologies Inc is a good buy right now due to its current price of $65.74, which is below the analyst price targets of $85 and $93 from Barclays and Needham, respectively. The company has shown a positive trend with a 5-day change of +2.26% and a recent dividend increase of 14%, reflecting strong financial health. However, the main risk is the year-to-date change of -20.62%, indicating potential volatility in the stock's performance.